EGFR mutation status in plasma and tumor tissues in non-small cell lung cancer serves as a predictor of response to EGFR-TKI treatment.
about
Next-generation sequencing: advances and applications in cancer diagnosisCross-Platform Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient PlasmaComparison of small biopsy specimens and surgical specimens for the detection of EGFR mutations and EML4-ALK in non-small-cell lung cancer.Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma.Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.COLD-PCR Technologies in the Area of Personalized Medicine: Methodology and Applications.Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer.Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay.MicroRNAs associated with therapy of non-small cell lung cancer.Liquid Biopsy as Surrogate to Tissue in Lung Cancer for Molecular Profiling: A Meta-Analysis
P2860
Q28073891-0158C029-55BB-4EAD-BBFA-B9D64BDC4A64Q33703063-F207FB8E-64CB-4CD8-B693-B0B24E510D4AQ37644815-51A41D79-7487-4DD0-A2D1-C90287BCF7B8Q38679628-7F9EAC2F-1EB4-466C-8AAE-A8FCBC963C09Q38824891-D262B4A6-691E-477A-9241-61563AA9D435Q39094514-5E77FFC5-222E-493E-8EC5-7CD4EC351DDEQ41260159-7DC9409B-0800-4A9D-AE3C-70DCE2BAF0A2Q44658595-DF3824BD-3303-48BE-9331-86769F18E6D6Q53688073-32B1F013-C52F-440A-BB26-025899858767Q57147737-A06343A4-0A49-4D3B-8F10-4F6A5718B313
P2860
EGFR mutation status in plasma and tumor tissues in non-small cell lung cancer serves as a predictor of response to EGFR-TKI treatment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
EGFR mutation status in plasma ...... esponse to EGFR-TKI treatment.
@en
type
label
EGFR mutation status in plasma ...... esponse to EGFR-TKI treatment.
@en
prefLabel
EGFR mutation status in plasma ...... esponse to EGFR-TKI treatment.
@en
P2093
P2860
P1476
EGFR mutation status in plasma ...... esponse to EGFR-TKI treatment.
@en
P2093
Baojian Zhao
Hualiang Xiao
Qiushi Wang
P2860
P304
P356
10.1080/15384047.2016.1139238
P577
2016-01-19T00:00:00Z